The multidisciplinary heart team should serve as the gatekeeper for treatment decisions and cost reimbursement qualification for transcatheter aortic valve implantation in patients with aortic stenosis.
The Dutch Working Group of Transcatheter Heart Valve Interventions strongly endorses the central role of the multidisciplinary heart team in individualizing treatment decisions for patients with aortic stenosis.
The current paper presents a position statement of the Dutch Working Group of Transcatheter Heart Valve Interventions that describes which patients with aortic stenosis should be considered for transcatheter aortic valve implantation and how this treatment proposal/decision should be made. Given the complexity of the disease and the assessment of its severity, in particular in combination with the continuous emergence of new clinical insights and evidence from physiological and randomised clinical studies plus the introduction of novel innovative treatment modalities, the gatekeeper of the treatment proposal/decision and, thus, of qualification for cost reimbursement is the heart team, which consists of dedicated professionals working in specialised centres.
Jaegere et al. (Fri,) conducted a review in Aortic stenosis. Transcatheter aortic valve implantation (TAVI) vs. Surgical aortic valve replacement (SAVR) was evaluated. The multidisciplinary heart team should serve as the gatekeeper for treatment decisions and cost reimbursement qualification for transcatheter aortic valve implantation in patients with aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: